Alirocumab (anti-PCSK9)

Ask supplier a question | View on supplier's website

Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation.

Supplier	Selleck Chemicals
Product #	A2047
Sku #	A2047-1mg*5
Pricing	1mg*5, $3290.00

Feedback